Paper · 409950

Prostaglandin-producing suppressor cells in Hodgkin's disease.

Goodwin JS and 5 others. N Engl J Med, 1977. Cited by 598 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Prostaglandin-producing suppressor cells in Hodgkin's disease. Papers, record 409950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/409950

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Prostaglandin-producing suppressor cells in Hodgkin's disease.; PubMed
Journal: N Engl J Med; PubMed
Year: 1977; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/409950/; PubMed
DOI: https://doi.org/10.1056/nejm197711032971802; PubMed
The journal: https://conductscience.org/library/journal-index/0255562; PubMed
Citations, by iCite: 598; iCite
Relative citation ratio, by iCite: 20.7; iCite
Revised in PubMed: 2021-12-03; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Goodwin JS	J S
2	Messner RP	R P
3	Bankhurst AD	A D
4	Peake GT	G T
5	Saiki JH	J H
6	Williams RC Jr	R C

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Hodgkin Disease	Major topic
Immunosuppression Therapy	Major topic
Lymphocytes	Major topic
Prostaglandins	Major topic
Adult
Cell Adhesion
Cyclooxygenase Inhibitors
Female
Humans
Indomethacin
Lectins
Male
Middle Aged
Prostaglandins E

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by120

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 598 citations.

PMID	Title	Journal	Year	In Papers	Source
24,386,144	A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.	PLoS One	2013	https://conductscience.org/library/papers/24386144	PubMed
22,275,973	Defeating cancer with antidepressants.	Ecancermedicalscience	2008	https://conductscience.org/library/papers/22275973	PubMed
11,911,341	Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.	Dig Dis Sci	2002	https://conductscience.org/library/papers/11911341	PubMed
9,539,645	Flow cytometric method to detect lymphocyte transformation in drug-allergic hepatic injury.	Dig Dis Sci	1998	https://conductscience.org/library/papers/9539645	PubMed
9,391,255	Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury.	Gut	1997	https://conductscience.org/library/papers/9391255	PubMed
7,712,593	Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.	Cancer Metastasis Rev	1994	https://conductscience.org/library/papers/7712593	PubMed
7,642,688	Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in rats.	J Cancer Res Clin Oncol	1995	https://conductscience.org/library/papers/7642688	PubMed
7,370,437	[The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].	Blut	1980	https://conductscience.org/library/papers/7370437	PubMed
7,337,972	Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.	Clin Exp Immunol	1981	https://conductscience.org/library/papers/7337972	PubMed
7,307,347	Generation of a soluble immune response suppressor factor (IRSF) by unstimulated leukocytes of healthy subjects.	Clin Exp Immunol	1981	https://conductscience.org/library/papers/7307347	PubMed

1 to 10 of 120

See all 120 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/409950

GET https://conductscience.org/api/papers/v1/409950/cited_by?page=2

API reference For AI assistants